DONATE NOW
Taking Out Toxo
  • Home
  • All About Toxoplasmosis
    • About Toxo
    • Screening/Diagnosis
    • Prevention
    • Treatment
    • Resources for Clinicians
    • Resources for Scientists
  • Research
    • Recent Research News
  • Get Involved
    • Donate Now
    • Corporate & Industry Partners
    • Fundraising & Events >
      • Taking Out Toxo Challenge 2017
      • Ways to Give or Fundraise
  • About Us
    • Our Organization >
      • Mission
      • History
      • Contact Us
    • Our Stories >
      • Blythe's Story
      • Suzanne's Story
    • Leadership Teams >
      • TOT Board of Directors
      • Scientific Advisory Board
  • Home
  • All About Toxoplasmosis
    • About Toxo
    • Screening/Diagnosis
    • Prevention
    • Treatment
    • Resources for Clinicians
    • Resources for Scientists
  • Research
    • Recent Research News
  • Get Involved
    • Donate Now
    • Corporate & Industry Partners
    • Fundraising & Events >
      • Taking Out Toxo Challenge 2017
      • Ways to Give or Fundraise
  • About Us
    • Our Organization >
      • Mission
      • History
      • Contact Us
    • Our Stories >
      • Blythe's Story
      • Suzanne's Story
    • Leadership Teams >
      • TOT Board of Directors
      • Scientific Advisory Board

The Toxoplasmosis Research Institute and Center at The University of Chicago


The Toxoplasmosis Research Institute is a not-for-profit (501c3) foundation with the goals of performing and promoting research and education concerning toxoplasmosis and optimal care for persons afflicted with toxoplasmosis and related diseases.

Dr. Rima McLeod is the President of the Toxoplasmosis Research Institute as well as a globally recognized expert on the disease.  She is also an incredibly kind woman who gives hope to the families of children with Toxoplasmosis. Recently, Blythe reached out to Dr. McLeod to find out what the researchers at the Institute are working on.  Dr. McLeod's response:

We are now developing/improving a potential compound (moving early toward a medicine) to cure/eliminate completely the untreatable dormant phase of the T.gondii.

We have an early perfect vaccine for mice that can teach us how to improve this to make a vaccine for humans.

We are working on understanding why certain people develop disease due to Toxoplasma. That is understanding the genetics of Susceptibility and resistance which is teaching us new ways the parasite may be eliminated.

We have found that active T.gondii infections occur in families because families share the risk factors.​
ALL ABOUT TOXOPLASMOSIS
About Toxo
​Screening/Diagnosis
Prevention
Treatment
Resources for Clinicians
Resources for Scientists
RESEARCH
​Recent Research News
GET INVOLVED
Donate Now
Corporate & Industry Partners
​Fundraising & Events
ABOUT US
Our Organization
​Our Stories
​Leadership Teams
donate now
Website by RyTech, LLC